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Abstract: Medical device-associated staphylococcal infections are a common and challenging problem.
However, detailed knowledge of staphylococcal biofilm dynamics on clinically relevant surfaces is
still limited. In the present study, biofilm formation of the Staphylococcus aureus ATCC 25923 strain
was studied on clinically relevant materials—borosilicate glass, plexiglass, hydroxyapatite, titanium
and polystyrene—at 18, 42 and 66 h. Materials with the highest surface roughness and porosity
(hydroxyapatite and plexiglass) did not promote biofilm formation as efficiently as some other
selected materials. Matrix-associated poly-N-acetyl-β-(1-6)-glucosamine (PNAG) was considered
important in young (18 h) biofilms, whereas proteins appeared to play a more important role at
later stages of biofilm development. A total of 460 proteins were identified from biofilm matrices
formed on the indicated materials and time points—from which, 66 proteins were proposed to
form the core surfaceome. At 18 h, the appearance of several r-proteins and glycolytic adhesive
moonlighters, possibly via an autolysin (AtlA)-mediated release, was demonstrated in all materials,
whereas classical surface adhesins, resistance- and virulence-associated proteins displayed greater
variation in their abundances depending on the used material. Hydroxyapatite-associated biofilms
were more susceptible to antibiotics than biofilms formed on titanium, but no clear correlation between
the tolerance and biofilm age was observed. Thus, other factors, possibly the adhesive moonlighters,
could have contributed to the observed chemotolerant phenotype. In addition, a protein-dependent
matrix network was observed to be already well-established at the 18 h time point. To the best of
our knowledge, this is among the first studies shedding light into matrix-associated surfaceomes of
S. aureus biofilms grown on different clinically relevant materials and at different time points.
Keywords: Staphylococcus aureus; biofilm matrix; clinical material; exopolysaccharide; proteins; surfaceome
1. Introduction
Implanted medical devices have been consistently shown to improve the quality of life of patients
suffering from critical conditions such as the destruction of joints [1]. Increasing life span and evolving
medical sciences have accelerated the use of such devices. However, paradoxically, this trend has
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also increased the propensity to device-associated infections. In joint replacements, infection rates
have been estimated to be approximately 1.7% in hip, 2% in knee and 9% in ankle prostheses [2].
In addition, 5–10% of inserted internal fixation devices can typically become infected [3]. Elderly, obese,
malnourished, diabetic and rheumatic patients and near-surface body inserts with poor soft tissue
coverage are most vulnerable to such infections. Medical device-associated infections are common
complications of implantation surgery caused by material-colonizing microbial communities, also
known as biofilms [1].
Staphylococcal spp. biofilms are one of the frequent causes of certain medical device-associated
infections, such as infections related to intravenous catheters [4,5], cardiac pacemakers [6] and mammary
implants [7,8]. In prosthetic joint infections, especially Staphylococcus aureus is largely responsible for
early post-interventional infection types [9]. Biofilms refer to complex communities of bacteria, which
can be attached to a surface or form aggregates without attachment to any surface. Biofilms differ from
free-floating cells by slow growth and tolerance to antibiotics and immune cells of the host [10–13].
Freely floating bacteria are responsible for colonizing new niches, while the biofilm lifestyle, preferred
by most of the bacteria, serves as a survival strategy against external threats [14]. Increased adaptation,
adherence and antibiotic tolerance are characteristic features of the bacterial biofilm. These features are
to a great extent connected to a slimy structure surrounding the bacterial cell community known as
the biofilm matrix, which forms approximately 90% of the biofilm dry mass and it is comprised of
hydrated extracellular polymeric components (EPS), such as exopolysaccharides, proteins, lipids and
nucleic acids [15]. The biofilm matrix is likely to change as biofilms develop over time, and it is also
different between biofilms formed on different surfaces. Those changes in the biofilm matrix are likely
crucial for understanding antibiotic tolerance and designing better anti-biofilm therapies. However,
the dynamics of such changes have been poorly investigated, thus far.
Bacteria may colonize indwelling medical devices during implantation or at later stages by
hematogenous seeding. After implantation, medical devices are promptly coated by host proteins,
involving fibrinogen, fibronectin and fibrin, which can facilitate adhesion of bacteria like Staphylococcus
aureus that express receptors for binding these plasma proteins [16,17]. The implant-induced changes
in the host, such as reduced blood flow and impaired activity of lymphocytic and phagocytic cells, are
other factors that can also promote the biofilm formation on medical devices [1]. Besides, some substrate
materials such as polymethyl methacrylate, acrylic glass (PMMA) can intrinsically contribute to biofilm
formation by hampering the complement and reducing leukocytic activity. Notably, phagocytic
cells often focus on degrading the medical device itself, not the bacteria. Strategies to cope with
such infections have involved systemically administered antibiotics [18]. However, achieving an
adequate concentration of the antibiotic at the biofilm infection site is difficult due to reduced local
tissue perfusion and compromised vasculature [19,20]. Thus, removal of the device and debridement
of the necrotic tissue is often required in conjunction with the insertion of a new medical device,
which often leads to revision surgeries and prolonged hospitalization periods with a high risk for
re-infections [3,21]. A systemic antibiotic prophylaxis during the time of the surgery together with the
coating of the inserted devices have been suggested among the strategies to improve clinical outcomes
with implanted medical devices [18].
A wide range of different implant materials are used in orthopedics. Despite the intensive research
currently being performed on different technologies for incorporating antimicrobial agents [22–32],
only a few studies investigating biofilm formation on different clinically relevant implantation materials
have been published [33–38]. The dynamic changes associated with biofilm growth [39] make biofilm
eradication from clinical materials even more challenging. As structural and functional features
of biofilms are greatly dependent on the material and the biofilm growth conditions [38,40,41],
there is an obvious demand for comprehensive studies investigating the structural and functional
features of the prosthetic materials together with biofilm dynamics on these materials. In this
context, the cell surface-associated adhesins have attracted great interest, as many of these can
contribute to protein-mediated biofilm formation [39,42–46]. Recently, an unacknowledged group of
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surface-associated proteins, i.a., moonlighting virulence factors and cytoplasmic proteins embedded
in the staphylococcal biofilm matrix, was proposed to form a new molecular mechanism conferring
increased stability for biofilm population [47]. High levels of intracellular cytoplasmic proteins and,
to a much lesser extent, extracellular or cell-surface adhesins have also been identified from in vivo
biofilm matrices using a rat model of orthopedic implant-associated chronic S. aureus infection [48].
Whether these moonlighters play a role during the formation of S. aureus biofilms on different prosthetic
materials is not yet clear.
Thus, the aim of the present study was to compare the biofilm characteristics of a S. aureus
biofilm-forming model strain ATCC 25923 (also known as strain Rosenbach or Seattle 1945) [49] on
different clinically pertinent substrates, involving borosilicate glass, plexiglass, hydroxyapatite and
titanium, using polystyrene as the reference material. Borosilicate glass (G) has been traditionally
used in artificial hip joints, bone cements, dental composite materials, prosthetic eyes and breast
implants [50,51], while plexiglass (PG) is used in bone cements [52]. Joint implants are made of
titanium alloys (TI) due to their biocompatibility and corrosion resistance, while hydroxyapatite (HA),
a known mineral component of bones, is used to coat medical devices for improving the integration
of the implant with newly formed bone [53]. The present study focused on (1) comparing the
susceptibility of these clinically relevant surfaces to biofilm formation, (2) studying the time-dependent
variations in exopolysaccharide and protein compositions of the biofilms on the indicated materials,
and (3) identifying the core surfaceome (proteins present in all aged biofilms (18, 42, and 66 h) on
every material) contributing to adherence/adherent growth. The present study demonstrates a number
of material- and time point-dependent surfaceome changes. As a main finding, matrix-associated
poly-N-acetyl-β-(1-6)-glucosamine (PNAG) was regarded as important in young (18 h) biofilms,
whereas proteins had a more pivotal role at later stages of biofilm development.
2. Materials and Methods
2.1. Materials
Tryptic soy agar (TSA) and tryptic soy broth (TSB) were acquired from Lab M Limited (Lancashire,
UK), while sucrose was from Merck (Darmstadt, Germany). Sequencing-grade modified trypsin
(porcine) was purchased from Promega Corp. (Madison, WI, USA). Wheat germ agglutinin Alexa
Fluor® 488 conjugate (WGA) was obtained from Invitrogen™, Thermo Fisher Scientific (Eugene, OR,
USA). Dimethyl sulphoxide (DMSO) was purchased from VWR International (Fontenay-sous-Bois,
France) and phosphate-buffered saline (PBS) was supplied by Lonza (Verviers, Belgium). Trifluoroacetic
acid (99%), triethylammonium bicarbonate buffer (TEAB; 1.0 M, pH 8.5), Tween® 20, vancomycin
hydrochloride hydrate, penicillin G sodium salt, levofloxacin and doxycycline hydrochloride were
purchased from Sigma-Aldrich (Steinheim, Germany).
2.2. Atomic Force Microscopy (AFM)
The topography of the material surfaces (borosilicate glass, G; plexiglass, PG; hydroxyapatite, HA;
titanium, TI and polystyrene, PS) was characterized with an NTegra Prima AFM (NT-MDT, Moscow,
Russia) in an intermittent contact mode by using Au-coated NSG10 (NT-MDT, Moscow, Russia) probes
with a nominal tip curvature radius of 10 nm and a force constant of 3.1–37.6 N/m. A scan rate of
0.3–0.5 Hz was used. Image analysis was conducted by using the Scanning Probe Image Processor
software (SPIP, Image Metrology, Hørsholm, Denmark). Captured topographs were processed with
Gaussian (ISO 11562) filtering.
2.3. Bacterial Culture and Biofilm Formation
The clinical strain Staphylococcus aureus ATCC 25923 was cultured in TSB at 37 ◦C under aerobic
conditions with shaking (220 rpm) to reach the exponential phase, to a concentration of 108 CFU·mL−1.
The bacterial concentration was estimated by measuring optical density at 595 nm (Varioskan™
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LUX Multimode Microplate Reader, Thermo Scientific, Vantaa, Finland) and later confirmed by
calculating colony-forming units (CFUs) on TSA plates. Biofilms were formed on 96-well plates
(96-WPs) (Nunclon™ ∆ surface polystyrene plates, Nunc™, Roskilde, Denmark) or on coupons made
of borosilicate glass (G), plexiglass (PG), titanium (TI) with dimensions: 0.4 cm height, 1.27 cm
diameter; and hydroxyapatite (HA) with dimensions: 0.25 cm height, 1.27 cm diameter (BioSurface
Technologies Corporation, Bozeman, MT, USA). For the experiments with coupons, they were placed
in a polystyrene 12-WP (Costar®, flat bottom, well diameter 2.26 cm; Corning Inc., Corning, NY, USA).
For the experiments performed in 12-WPs (with the coupons on them) or 96-WPs, 2.5 mL or 200 µL of
the bacterial suspension (106 CFU·mL−1) were used, respectively. The plates were incubated at 37 ◦C
under aerobic conditions with shaking (150 rpm) for 18, 42 or 66 h (the incubation times were based
on [54]). The media of the 42-h-old biofilms were changed after 18 h of incubation, whereas the media
of the 66-h-old biofilms were refreshed at 18 and 42 h.
2.4. Quantification of Biofilm Formation on Different Materials
S. aureus ATCC 25923 was grown on polystyrene (PS) (in 96-WP) or on borosilicate glass (G),
plexiglass (PG), hydroxyapatite (HA) and titanium (TI) coupons in 12-WP, as described above. After 18,
42 or 66 h, the biofilms formed on G, PG, HA or TI coupons were disaggregated for quantification as
follows. First, the coupons were soaked in the medium (TSB) to detach planktonic and loosely attached
bacteria, and then transferred into Falcon tubes of 50 mL containing 1 mL of 0.5% (w/v) Tween® 20-TSB
solution. In contrast, biofilms grown on 96-WPs were washed once with 200 µL of TSB, and 200 µL of
Tween® 20-TSB solution was added on wells. The tubes and the 96-WPs were sonicated in a water
bath in Ultrasonic Cleaner 3800 (Branson Ultrasonics, Danbury, CT, USA) at 25 ◦C, 35 kHz, for 5 min.
Serial dilutions (10−1–10−8) were performed from the resulting bacterial suspensions onto TSA plates.
Size differences between coupons and 96-WPs were taken into account by measuring colony-forming
units (CFU) per volume (mL) and area of bacterial attachment on the different surfaces (cm2) and
transforming the values of CFU·(mL·cm2)−1 to a log10 scale.
2.5. Quantification of Matrix-Associated Poly-N-Acetyl-β-(1-6)-Glucosamine
For quantifying matrix poly-N-acetyl-β-(1-6)-glucosamine (PNAG), S. aureus ATCC 25923 biofilms
were grown in 96-WPs and on coupons in 12-WPs for 18, 42 and 66 h, as described above. The previously
reported WGA staining protocol [54] was applied with two modifications: a lower concentration
(2.5 µg·mL−1) of WGA conjugate was used based on [55] and 100% DMSO was used to replace 33%
acetic acid, which is not compatible with acid-unbearable materials, such as HA. The selection of 100%
DMSO was based upon initial tests where a lower concentration of acetic acid (10% acetic acid), 96%
ethanol and 100% DMSO were tested (acquired assay quality parameters for DMSO: screening window
coefficient Z’ factor = 0.431; signal to noise (S/N) = 5.4; signal to background (S/B) = 9.2)
First, the 96-WPs were washed once with 200 µL of PBS, while the coupons were briefly soaked
once in PBS, to detach planktonic and loosely attached cells. Then, WGA in PBS (2.5 µg·mL−1) was
added onto 96-WPs (200 µL) or onto coupons (500 µL) in 24-WPs (Nunclon™ ∆ surface, Nunc™,
Roskilde, Denmark) and incubated in the darkness at 4 ◦C for 2 h. After the incubation, the biofilms
were washed three times with PBS and dried at room temperature (RT) for 15 min. Next, 200 µL
of DMSO was added into the 96-WPs. The coupons were transferred into Falcon tubes of 50 mL,
containing 1.3 mL (for G, PG and TI) or 1.11 mL (for HA coupons; smaller volume was due to the
smaller size of these coupons) of DMSO. The plates and the tubes were sonicated in a water bath at
25 ◦C, 35 kHz, for 30 s. Following an incubation at 37 ◦C for 1 h, the sonication step was repeated.
Finally, 200 µL of the remaining suspensions from Falcon tubes were transferred onto a 96-WP to
measure top fluorescence with Varioskan™ LUX Multimode Microplate Reader (λexcitation = 495 nm;
λemission = 520 nm). Before measuring the fluorescence signal from biofilms formed on 96-WPs, the
resulting suspensions were diluted 1:10 to be in correspondence with the coupon surface area.
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2.6. Fluorescence Imaging
These experiments were performed with S. aureus ATCC 25923 biofilms grown on G coupons,
stained with WGA as indicated above. After the 2-h-long incubation period (4 ◦C, in the darkness),
the unbound dye was removed, and images of the coupons on Petri dishes were acquired with an
Invitrogen™ EVOS® FL Imaging System (Life Technologies™, Eugene, OR, USA) using the Green
Fluorescent Protein (GFP) light cube (λexcitation = 470/22 nm; λemission = 510/42 nm) and a 20× objective.
2.7. Trypsin Shaving of Matrix-Associated Proteins
Before protein identification, biofilm viability with and without the trypsin treatment was first
assessed to exclude possible effects of trypsin on biofilm integrity. Biofilms were grown on G coupons
in 12-WPs and then transferred into Falcon tubes (50 mL) containing 1 mL of 100 mM acetate buffer
(pH 4.7), a condition preventing the release of the adhesive moonlighting proteins [56]. The tubes
were sonicated (25 ◦C, 35 kHz, 5 min) and detached bacterial cells were collected by centrifugation
(4 ◦C, 4000× g, 2 min). The cells were suspended in 110 µL of 100 mM TEAB containing 16% sucrose
(TEAB-sucrose (16%); pH 8.5) with and without trypsin (at a final concentration of 51.9 ng·µL−1),
and the mixtures were incubated (37 ◦C, 15 min). Next, the cells were serially diluted in TSB and
plated onto TSA to determine CFUs. The number of viable counts remained the same in both samples,
excluding the possibility of trypsin-induced cell lysis (Figure S1) and confirming the suitability of the
shaving conditions for trypsin shaving.
Biofilm cells for trypsin shaving were prepared in duplicates for each substrate and time point
as follows. Biofilms attached to coupons were first rinsed with TSB to remove planktonic bacteria
and transferred onto 12-WPs. There, the cells were scraped off from the coupon surface into 100 mM
acetate buffer (4 ◦C, pH 4.7) using a sterile plastic stick. In the case of biofilms formed on PS, the
biofilms were also rinsed with TSB first and scraped off from 96-WPs into 100 mM acetate buffer.
In all cases, cells were collected by centrifugation (4 ◦C, 4000× g, 2 min) and suspended in 110 µL
of 100 mM TEAB-sucrose (16%) [57] and trypsin (at a final concentration of 51.9 ng·µL−1). After the
trypsin treatment (37 ◦C, 15 min), cells were first removed by centrifugation (RT, 4000× g, 2 min) and
digestions were further purified through cellulose acetate membranes (pore size 0.22 µm, Costar®
Spin-X Centrifuge Tube Filter, Corning Inc., Corning, NY, USA) by centrifugation (RT, 16000× g,
2 min). Digestions incubated at 37 ◦C for 16 h were blocked by adding trifluoroacetic acid to a final
concentration of 0.6%. Concentrations of released proteins/peptides were measured using low-volume
photometric quantification at 280 nm, with a µDrop™ Plate (Thermo Scientific, Vantaa, Finland) on a
Varioskan™ LUX Multimode Reader (Thermo Scientific, Vantaa, Finland).
2.8. Identification of Trypsin-Released Proteins/Peptides by LC–MS/MS
Tryptic peptides were purified and concentrated using ZipTips (C18; Millipore®, Merck KGaA,
Darmstadt, Germany) and peptides were analyzed essentially as described previously [58]. Briefly,
an equal amount of the purified tryptic peptides was submitted to an Easy-nLC 1000 Nano-LC
system (Thermo Scientific, Vantaa, Finland) coupled to a quadrupole Orbitrap mass spectrometer
(Q Exactive™, Thermo Scientific, Bremen, Germany) equipped with a nanoelectrospray ion source
(Easy-Spray™, Thermo Scientific, Vantaa, Finland). Liquid chromatography separation was performed
in an Easy-Spray™ column of 25 cm bed length (C18, 2 µm beads, 100 Å, 75 µm inner diameter, Thermo
Scientific), using a flow rate of 300 nL/min. The peptides were eluted with a 2–30% gradient of solvent
(composed of 100% acetonitrile and 0.1% formic acid) in 60 min. Acquired MS raw data were processed
using the MaxQuant version 1.6.2.1 [59] with built-in Andromeda search engine [60]. Database searches
were conducted against the UniProt S. aureus protein database (https://www.uniprot.org/). In these
searches, carbamidomethyl (C) was set as a fixed and methionine oxidation as a variable modification.
First search peptide tolerance of 20 ppm and main search error of 4.5 ppm were used. Trypsin without
proline restriction enzyme option was used, with two allowed miscleavages. The minimal unique
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+ razor peptides number was set to 1, and FDR to 0.01 (1%) for peptide and protein identification.
Known contaminants provided by MaxQuant, and proteins identified as “reverse” and “only identified
by site” were discarded from further data analyses. Only proteins that could be identified in both
replica samples were included in data set comparisons.
2.9. Chemotolerance Assays
S. aureus ATCC 25923 biofilms were grown on HA and TI coupons in 12-WPs for 18 and 66 h, as
previously described in Section 2.3. After the incubation, the chemotolerance assay was performed
essentially as described previously [28]. The coupons were soaked in TSB to detach planktonic cells and
transferred onto 12-WPs containing 2.5 mL of 2.0 µM penicillin G (0.71 µg/mL), 90.0 µM levofloxacin
(32.5 µg/mL), 4.0 µM doxycycline (1.92 µg/mL) or 5.0 µM vancomycin (7.43 µg/mL) or TSB (as a negative
control). The coupons were exposed to the indicated antibiotics for 2 or 24 h at 37 ◦C, under aerobic
conditions with shaking (150 rpm). After the treatment, biofilms were quantified as in Section 2.4.
A combination treatment involving trypsin (51.9 ng·µL−1) and 90 µM levofloxacin was also tested.
Therein, biofilms were formed on HA for 18 and 66 h, as above. After the incubation periods, the
coupons were soaked in TSB and transferred onto a 24-WP containing trypsin in buffer (35 µL of trypsin
in 350 µL of 100 mM TEAB-sucrose (16%)) or mere buffer (385 µL of 100 mM TEAB-sucrose (16%),
as a negative control). The 24-WPs were incubated at 37 ◦C for 15 min, as described in Section 2.7.
Next, the coupons were soaked in TSB, and transferred onto the 12-WP containing 2.5 mL of 90 µM
levofloxacin. The coupons were incubated with the antibiotic at 37 ◦C under aerobic conditions with
shaking (150 rpm) for 24 h. As a second control, biofilms were grown in TSB under similar conditions
for 24 h and 15 min. Biofilm formation on the materials was assessed as in Section 2.4. The anti-biofilm
effect of the antibiotics is expressed as a logarithmic reduction of the bacterial burden [61], using
Equation (1):
logR = log10〈(CFU/mL)control〉 − log10〈(CFU/mL)compound〉 (1)
where 〈·〉 denotes averaging over samples.
2.10. Data Processing and Statistical Analysis
For the optimization of the WGA staining protocol (Section 2.5), the following statistical parameters
were used: screening window coefficient Z′ factor, signal to noise (S/N) and signal to background (S/B)
(according to Equations (2)–(4)) [54,62,63].
Z′ = 1− (3 x SDmax + 3 x SDmin)|Xmax −Xmin| (2)
S
N
=
Xmax −Xmin
(SDmax2 + SDmin2)
1/2
(3)
S
B
=
Xmax
Xmin
(4)
One-way analysis of variance comparisons and Tukey (for equal variances) and Games–Howell
(for unequal variances) post-tests were executed using IBM SPSS Statistics (SPSS Inc., Chicago, IL, USA,
version 24.0 for Windows). In paired comparisons, the unpaired t-test with Welch′s correction was
used (GraphPad Software, Prism, La Jolla, CA, USA, version 7.0 for Windows). p < 0.05 was considered
statistically significant and p < 0.001 statistically highly significant. Each test was performed at least
in duplicate.
SPSS was also used in multivariate statistical analyses of the protein identification data, using
average relative intensity values obtained for proteins identified in both biological replicates. The values
of the commonly identified proteins were log2-transformed, and principle component analysis (PCA;
based on the correlation matrix) was performed using Oblimin rotation with Kaiser Normalization.
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3. Results
3.1. HA and PG Exhibited the Largest Surface Roughness
AFM topographical images of 96-well plates (made of polystyrene; PS) and borosilicate glass (G),
plexiglass (PG), hydroxyapatite (HA) and titanium (TI) coupons are shown in Figure 1. Materials PG and
HA are the most heterogeneous and uneven surfaces, whereas TI, PS and G appear to be much smoother.
Roughness analysis of the AFM images provided more quantitative insights into the differences between
the substrates (Table 1 and Figure S2). The surface area ratio (Sdr) describes the roughness-induced
increment of the interfacial surface area relative to the area of the projected flat plane, while Vv illustrates
the void volume, describing surface porosity. The surfaces of HA and PG showed the largest roughness
values (Sdr = 58 ± 10% and 123 ± 20%; Vv = 0.75 ± 0.08 µm3/µm2 and 0.62 ± 0.07 µm3/µm2, respectively)
(Table 1). The smoothest surface was observed to be G (Sdr = 0.3 ± 0.1%; Vv = 0.0048 ± 0.001 µm3/µm2).
The same trend was observed with length-scale dependent roughness (Figure S2).
Table 1. Selected roughness parameters of materials used in the assays. Sdr describes the relative
increase in surface area compared to the flat surface. Vv reflects void volume, describing the openness
of the surface or surface porosity.
Material Sdr (%) Vv (µm3/µm2)
Borosilicate glass 0.3 ± 0.1 0.0048 ± 0.001
Plexiglass 123 ± 20 0.62 ± 0.07
Hydroxyapatite 58 ± 10 0.75 ± 0.08
Titanium 9.0 ± 1.1 0.19 ± 0.02
Polystyrene 3.0 ± 0.4 0.012 ± 0.002
3.2. The Most Significant Time-Dependent Increase in Biofilm Formation Was Detected on HA
Attachment of S. aureus ATCC 25923 onto all five materials was compared at three incubation
time points (18, 42 and 66 h). The number of attached bacteria was expressed as log10 of viable
CFU·(mL·cm2)−1. In the assay conditions, viable colonies increased temporally in a statistically
significant manner only in two cases (PG and HA; from 18 to 42 h), while a non-significant trend
implying temporal decrease in cell viability was observed with biofilms on G and TI (Figure 2).
Comparisons between different materials at similar time points showed that S. aureus ATCC 25923 was
more prone to form biofilms on PS than on the other substrates. In addition, biofilm formation on PS
was equally high after 18, 42 or 66 h.
3.3. Temporal Decrease in the Total PNAG Amount Was Detected in All Biofilms
The exopolysaccharide amount was studied using a wheat germ agglutinin (WGA) conjugate
that targets the poly-N-acetyl-β-(1-6)-glucosamine (PNAG) fraction of the biofilm matrix. Using the
optimized staining conditions (described in Section 2.5), 18-, 42- and 66-h-old S. aureus ATCC 25923
biofilms were treated with WGA conjugate, after being formed on the indicated five substrate materials.
The PS-associated biofilms contained statistically more (p < 0.05) PNAG fraction than biofilms formed
on G, PG or TI (Figure 3). A temporal decline (from 18 to 66 h) in the PNAG fraction was noted for all the
tested substrate materials; the deepest decline was detected with biofilms on TI. The images presented
in Figure 4 confirm the declining trend for PNAG in 18- versus 42-h-old biofilms on G coupons, and
illustrate the macrostructural temporal evolution from thick, intermittent regions (Figure 4A; 18 h) to a
thinner, more cohesive PNAG network (Figure 4B; 42 h).
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Error bars denote the standard error of the ean (SE ) (n = 3). G, borosilicate glass; PG, plexiglass;
HA, hydroxyapatite; TI, titanium; PS, polystyrene.
Microorganisms 2019, 7, x FOR PEER REVIEW 10 of 30 
 
biofilms on G coupons, and illustrate the macrostructural temporal evolution from thick, intermittent 
regions (Figure 4A; 18 h) to a thinner, more cohesive PNAG network (Figure 4B; 42 h). 
 
Figure 3. Wheat germ agglutinin Alexa Fluor® 488 conjugate-based quantification of poly-N-acetyl-β-
(1-6)-glucosamine (PNAG) in S. aureus ATCC 25923. Differences in PNAG contents (expressed as 
relative fluorescence units (RFUs)) were assessed for a single material between different time points, 
and for a fixed time point between the different materials, using one-way ANOVA comparisons and 
Games–Howell post-tests for blank-corrected data points. *, significant difference (p < 0.05). Error bars 
denote the standard error of the mean (SEM) (n = 2). G, borosilicate glass; PG, plexiglass; HA, 
hydroxyapatite; TI, titanium; PS, polystyrene. 
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3.4. A Total of 66 Proteins Were Shared by All Biofilms
The protein concentration and the number of proteins were first examined in all biofilm matrices
at the indicated time points (18, 42 and 66 h). The clearest trend in time-dependent increase in the total
protein concentration was detected for biofilms formed on G and HA (Figure 5A). For the PG- and
PS-associated biofilms, the highest protein concentration was reached at the 42 h time point, although
later declined at 66 h in both cases.
Next, all the individual proteins were identified from the biofilm samples by trypsin shaving
and LC–MS/MS analyses. The combined surfaceome catalogs based on two independent experiments
enabled the identification of 460 proteins in total. An obvious trend of temporal increase in the number
of the identified proteins was observed with biofilms formed on HA and TI (Figure 5B). At the 18 h
time point, the highest number of proteins was identified from biofilms formed on PS (390 proteins),
and the lowest number with the biofilms formed on TI (76 proteins). The core surfaceomes (i.a., protein
orthologs shared by all samples) defined for biofilms growing on different materials at a fixed time
point indicated 67, 220 and 347 proteins that were shared by all 18, 42 and 66 h time point biofilms,
respectively (Figure 6A). The number of proteins common to all biofilms (detected on every material at
every time point) was 66 (Figure 6B). The highest number of proteins shared by all time points in fixed
materials was obtained with the PG and PS biofilms (PG, 329 proteins; PS, 383 proteins) (Figure S3).
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Figure 5. Protein concentrations mg·(mL·cm2)−1 (A) and the number of the identified matrix-associated
proteins (detected in both replicates) (B) of the S. aureus ATCC 25923 biofilms. Differences in protein
concentrations were assessed for a single material between different time points, and for a fixed time
point between the different materials, using one-way ANOVA comparisons and Tukey post-tests for
blank-corrected data points. *, significant difference (p < 0.05). Error bars denote the standard error of the
mean (SEM) (n = 2). G, borosilicate glass; PG, plexiglass; HA, hydroxyapatite; TI, titanium; PS, polystyrene.
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combination and time point (B). A three-dimensional principle component analysis (3D PCA) analysis
indicating outliers and clusters (circled) nested within the identified material- and time-dependent
biofilm surfaceomes (C).
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3.5. Protein Moonlighters Formed the Largest Fraction of the Core Surfaceome
Dynamics of relative protein abundance changes in each formed biofilm over time was investigated
next by three-dimensional principal component analysis (3D PCA). Figure 6C shows two major clusters;
the 42 h PS biofilm surfaceome together with those formed on each five materials for 66 h, while the
rest of the 42 h biofilm surfaceomes (G, HA, PG and TI) and those associated with PG- and PS at the
18 h time point formed the second cluster. Biofilms formed on TI-, G- and HA-coupons at the 18 h time
point were clearly separated from the two main clusters, implying that these three materials affected
the adherence in young biofilms (during 18 h). Altogether, the 3D PCA analysis revealed that TI, G
and HA promoted specific surfaceome changes in biofilms already at the 18 h time point.
Table 2 illustrates changes in protein abundances in relation to time and different substrates.
The most dominating proteins in all materials and time points were identified either as known or
potential moonlighting proteins. Among these, the ribosomal proteins (r-proteins) formed the biggest
group. Other moonlighters identified in all materials and time points included enzymes with a role in
glycolysis (enolase (ENO); glyceraldehyde-3-phosphate dehydrogenase (GaPDH); triosephosphate
isomerase (TPI); pyruvate kinase (PYK); pyruvate dehydrogenase E1 (PDHB); phosphoglycerate kinase
(PGK); l-lactate dehydrogenase 1 (l-LDH) and alcohol dehydrogenase (ADH)), protein synthesis
(elongation factor Tu (EfTU); elongation factor G (EfG) and elongation factor P (EfP)), and stress
(chaperone protein (DnaK); universal stress protein (SAV1710), Usp and alkyl hydroperoxide reductase
(AhpC)). Among these, the predicted abundances of EfTU, PGK, ENO and GaPDH reached the highest
level at 66 h, which clearly exceeded those detected for the r-proteins. The Clp family proteins (ClpP,
ClpL, ClpC and ClpB) also displayed material-dependent variation; their abundances displayed
temporal increase in all biofilm matrices. The Clp proteins were not detected at the 18 h time point
of TI.
Table 2. A heatmap comparing the intensity values (log10) of selected protein identification.
Protein Name Acc. No. a
18 h 42 h 66 h
PS G HA PG TI PS G HA PG TI PS G HA PG TI
Bifunctional autolysin—AtlA Q6GI31
Immunoglobulin G-binding protein A—Spa P38507
Immunoglobulin-binding protein—Sbi Q6GE15
Immunodominant antigen B—IsaB Q6GDG4
Immunodominant antigen A—IsaA Q6GDN1
Malate:quinone oxidoreductase 2—MQO2 Q6GDJ6
Leukocidin-like protein 2—Luk2 Q6GF49
Leukocidin-like protein 1—Luk1 Q6GF50
Non-heme ferritin—FtnA Q99SZ3
Foldase protein A—PrsA Q6GFL5
Thioredoxin Q6GHU0
Staphylococcal secretory antigen—SsaA Q99RX4
Putative dipeptidase SAR1836 Q6GFV0
Clp protease proteolytic subunit—ClpP Q6GIM3
Clp ATPase ClpC Q99W78
Clp ATPase ClpL Q6GDQ0
Clp ATPase ClpB Q6GIB2
Gamma-hemolysin component B—HlgB Q6GE12
Protein RecA Q6GHF0
Bone sialoprotein-binding protein—Bbp Q6GJA6
Clumping factor B—ClfB Q6GDH2
Clumping factor A—ClfA Q6GIK4
Delta-hemolysin—HglD Q6GF37
Virulence factor—EsxA Q99WU4
ATP-dependent protease ATPase—HslU Q6GHI1
Elastin-binding protein—EbpS Q6GGT1
Fibrinogen-binding protein—FbnBP Q6GHS9
Fibronectin-binding protein A—FnBPA Q6GDU5
Ser-Asp repeat-containing protein C—SdrC Q6GJA7
Ser-Asp repeat-containing protein D—SdrD Q8NXX6
Catabolite control protein A—CcpA Q6GFX2
Microorganisms 2019, 7, 584 13 of 27
Table 2. Cont.
Protein Name Acc. No. a
18 h 42 h 66 h
PS G HA PG TI PS G HA PG TI PS G HA PG TI
Response regulator—CodY Q6GHI0
Response regulator—SarA Q7A732
Response regulator—Rot Q9RFJ6
Response regulator—SarR Q9F0R1
Response regulator—SarS Q7A872
Response regulator—VraR Q7A4R9
Response regulator—SaeR Q99VR7
Response regulator—MsrR Q99Q02
Response regulator—MraZ Q6GHQ7
Response regulator—LytR P52078
Response regulator—NrdR Q6GG20
Response regulator—GraR Q6GJ11
HTH-type transcriptional regulator—MgrA Q99VT5
Redox-sensing repressor—Rex Q6GF26
SOS response repressor—LexA Q9L4P1
Oxygen regulatory protein—NreC Q99RN8
Regulatory protein—Spx Q6GI88
Histidine protein kinase—SaeS Q99VR8
RNA polymerase sigma factor SigA Q99TT5
Anti-sigma-B factor antagonist—RsbV Q6GF07
Iron-regulated surface determinant—IsdB Q6GHV7
Lysostaphin resistance protein A—LyrA Q6GEA0
Methicillin-resistance protein—FmtA Q6GI27
Conserved virulence factor B—CvfB Q99U93
DegV domain-containing protein SAR1438 Q6GGY2
Signal transduction protein TRAP Q6GFM2
Staphopain A (cysteine protease)—SspP Q6GFE8
Ferrochelatase—HemH Q6G8A3
Phospholipase C—PlC Q5HEI1
Methicillin resistance-associated—FemA Q99UA7
Methicillin resistance-associated—FemB Q6GH30
Probable cell wall amidase—LytH Q7A588
ATP-dependent protease subunit—HslV Q6GHI2
CtpA-like serine protease Q6GGY8
HtrA-like serine protease Q6GI62
Hydrolase encoded by the agr operon P55177
Probable thiol peroxidase Q6GFZ4
Uncharacterized oxidoreductase SAR2567 Q6GDV6
Peptide methionine sulfoxide reductase MsrB Q6GGY4
Heme-dependent peroxidase (SAV0587) Q99W24
Thioredoxin reductase Q6GB66
NADPH-dependent oxidoreductase Q6GJR6
Multicopper oxidase—Mco Q6GIX3
Nitric oxide synthase oxygenase Q6GFE2
Putative NAD(P)H nitroreductase (SAV2523) Q99RB2
FMN-dependent NADPH-azoreductase Q99W49
Staphylocoagulase—Coa P17855
Iron-sulfur cluster repair protein—ScdA Q6GK53
Urease accessory protein G—UreG Q99RX9
ATP synthase epsilon chain Q6GEX3
ATP synthase subunit delta Q6GEW9
ATP synthase gamma chain Q99SF4
30S ribosomal protein S1 Q6GGT5
30S ribosomal protein S10 Q931G5
30S ribosomal protein S11 Q6GEK8
30S ribosomal protein S12 Q6GJC3
30S ribosomal protein S13 Q6GEK7
30S ribosomal protein S15 Q99UJ9
30S ribosomal protein S16 Q6GHJ7
30S ribosomal protein S17 Q8NVB4
30S ribosomal protein S18 Q6GJV1
30S ribosomal protein S19 Q6GEI7
30S ribosomal protein S2 Q6GHH9
30S ribosomal protein S20 Q99TR3
30S ribosomal protein S21 Q6GGC5
30S ribosomal protein S3 Q6GEI9
30S ribosomal protein S4 Q6GFY8
30S ribosomal protein S5 Q6GEK0
30S ribosomal protein S6 Q6GJV3
30S ribosomal protein S7 Q6GJC2
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Table 2. Cont.
Protein Name Acc. No. a
18 h 42 h 66 h
PS G HA PG TI PS G HA PG TI PS G HA PG TI
30S ribosomal protein S8 Q6GEJ7
30S ribosomal protein S9 Q6GEL8
50S ribosomal protein L1 Q6GJD0
50S ribosomal protein L10 Q6GJC9
50S ribosomal protein L11 Q6GJD1
50S ribosomal protein L13 Q99S51
50S ribosomal protein L14 Q99S31
50S ribosomal protein L15 Q6GEK2
50S ribosomal protein L16 Q99S28
50S ribosomal protein L17 Q99S46
50S ribosomal protein L18 Q99S37
50S ribosomal protein L2 Q6GEI6
50S ribosomal protein L20 Q6GG27
50S ribosomal protein L21 Q99TK6
50S ribosomal protein L22 Q99S26
50S ribosomal protein L23 Q99S23
50S ribosomal protein L24 Q6GEJ4
50S ribosomal protein L25 Q99WA2
50S ribosomal protein L27 Q931Q3
50S ribosomal protein L28 Q6GHL1
50S ribosomal protein L29 Q6GEJ1
50S ribosomal protein L3 Q6GEI3
50S ribosomal protein L30 Q6GEK1
50S ribosomal protein L31 Q6GEV5
50S ribosomal protein L35 Q6GG26
50S ribosomal protein L4 Q6GEI4
50S ribosomal protein L5 Q99S33
50S ribosomal protein L6 Q99S36
50S ribosomal protein L7/L12 Q6GJC8
50S ribosomal protein L9 Q6GKT0
Elongation factor Tu—EfTU Q6GJC0
Elongation factor G—EfG Q6GJC1
Translation initiation factor IF-3—InfC Q6GG25
Translation initiation factor IF-2—InfB Q6GHG6
Elongation factor P—EfP Q6GGH0
Glyceraldehyde-3-phosphate dehydrogenase Q6GIL8
Enolase—ENO Q6GIL4
Phosphoglycerate kinase—PGK Q6GIL7
Pyruvate kinase—PYK Q6GG09
Fructose-bisphosphate aldolase class 1—FBA Q6GDJ7
Pyruvate dehydrogenase E1—PDHB Q6GHZ1
Triosephosphate isomerase—TPI Q6GIL6
ATP-dependent
6-phosphofructokinase—PFK Q6GG08
2,3-phosphoglycerate mutase—PPGM Q6GE17
Aconitase A—AcnA Q6GH55
L-lactate dehydrogenase 1—L-LDH Q6GK73
D-lactate dehydrogenase—D-LDH Q6GDS2
Alkaline shock protein 23—Asp23 Q6GEP7
Alcohol dehydrogenase—ADH Q99W07
Trigger factor—Tf Q6GG30
DNA-directed RNA polymerase—RpoB Q6GJC5
Alkyl hydroperoxide reductase—AhpC Q6GJR7
Alkyl hydroperoxide reductase—AhpF Q6GJR8
Chaperone protein—GroEL Q6GF43
Chaperone protein—DnaK Q6GGC0
Chaperone protein—DnaJ Q6GGC1
10 kDa chaperonin Q6GF42
Universal stress protein (SAV1710)—Usp Q99TF3
Superoxide dismutase [Mn/Fe] 1—SodA Q6GGE6
DNA mismatch repair protein—MutL Q93T05
Thermonuclease Q5HHM4
Glutamine synthetase Q6GHC6
Color gradient from red to green is used to indicate decreasing intensity values.
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A high number of different virulence factors and factors conferring increased resistance to one or
several antibiotics were also detected (Table 2). From these, gamma-hemolysin component B (HlgB),
leukocidin-like proteins (Luk1/2), IgG-binding proteins (Sbi and Spa) and immunodominant antigens
(IsaA and IsaB) were among the high abundant proteins in all materials at each time point. Several
regulatory proteins were present in one or several of the materials already in young biofilms—among
these, the relative abundance of CcpA, CodY, SarR, SaeR, Rot, MsrR, Rex and VraR increased over time,
reaching the highest level at the 66 h time point. Enzymes involved in maintaining the cellular redox
state (e.g., peptide methionine sulfoxide reductase (MsrB)) were either present or absent at 18 h in
biofilms but could be detected with higher identification scores in all biofilms at the 42 and 66 h time
points (Tables S1 and S2).
3.6. Greatest Time-Dependent Variations Were Observed for TI- and HA-Associated Surfaceomes
Comparing the number of uniquely identified proteins at different time points of growth revealed
the greatest differences in TI- and HA-associated surfaceomes (Figure S3). These surfaceomes displayed
a relatively high number of specific proteins at 66 h (HA, 74 proteins; TI, 169 proteins) and proteins
shared by these two matrices at the 42 and 66 h time points (HA, 142 proteins; TI, 164 proteins) could
not be identified in other biofilm matrices. Of note, at the 18 h time point, TI-associated biofilm cell
surfaces were devoid of several proteins that were identified from other biofilms at this time point.
The classically secreted cell wall/membrane-anchored adhesins were either present or absent in one or
several of the investigated biofilms at the 18 h time point (Table 2). These included the fibronectin (FnBPA)
and fibrinogen binding proteins (FbnBP). For instance, FnBPA was not detected in PS, HA or TI biofilms,
while HA biofilms lacked the FbnBP adhesion at this growth stage (18 h). The bone sialoprotein-binding
protein (Bbp) was not present in G and TI biofilms (18 h), while elastin binding proteins S (EbpS) was
detected only in PS and G biofilms. The clumping factors A and B (ClfA, ClfB) were also differently
abundant on the tested materials at the 18 h time point: ClfA was specific to PS and PG biofilms, while
ClfB was detected on every material except on TI. On the other hand, adhesins that were not detected
at the 18 h time point (or detected with lower abundances) could be identified with reasonably high
identification scores at the later time points of growth (42- and/or 66 h). Such proteins included Bbp,
FbnBP and the clumping factors ClfA and ClfB. In addition, FnBPA was not identified in any biofilm
surfaceomes at the later time point (66 h). Glutamine synthetase, a potential moonlighting adhesin, was
specifically identified only in TI biofilms at each time point of growth.
3.7. Antibiotic Susceptibility Depends on the Composition of the Biofilm Surfaceome
Based on the observed biofilm characteristics (number of cells, PNAG and protein content) the
HA- and TI-associated biofilms were further tested with different antibiotics. To this end, 18 and
66 h biofilms were exposed to four different antimicrobial (vancomycin, penicillin G, doxycycline,
levofloxacin) agents for 2 or 24 h. As shown in Figure 7 the viable cell counts (CFUs) decreased in
a statistically significant manner (p < 0.05 and p < 0.001) in all cases with the 24-h-long exposure
when compared to the TSB-treated control coupons containing biofilm cells. A comparison of the
used materials indicated that the 66-h-old biofilms on HA exposed to antibiotics for 2 h were more
susceptible than biofilms on TI in all of the cases (Table 3). In general, biofilms formed on HA seemed
to be more susceptible than in TI to antibiotics in most of the cases (in eight out of 11). When taking the
biofilm age-related differences into account, the 66-h-old biofilms were found more susceptible than
the 18-h-old biofilms in three out of 10 cases. In most of the cases (in seven out of 10), the younger
biofilms (18 h) were more susceptible than the older (66 h) biofilms. Comparing the antibiotic treatment
times indicated that increasing the exposure time from 2 to 24 h resulted in reduced chemotolerance
in each biofilm age- and material-combination. From the tested antibiotics, levofloxacin at a final
concentration of 90 µM was found as the most efficient in reducing the viable colonies from biofilms
formed on both materials. The most efficient antibiotic treatment was obtained with 18-h-old biofilms
exposed to levofloxacin for 24 h.
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grey bars illustrate 18- and 66-h-old biofilms (respectively) with 24-h-long antibiotic exposure. The 
results of antibiotic-treated biofilms were compared to TSB-treated biofilms. The statistical analysis 
was performed by using unpaired t-tests with Welch’s correction. * p < 0.05 and *** p < 0.001 were 
considered statistically significant and highly significant, respectively. Error bars denote the standard 
error of the mean (SEM) (n = 2). 
  
Figure 7. The chemotolerance of 18- and 66-h-old S. aureus ATCC 25923 biofilms formed on hydroxyapatite,
HA (A) and titanium, TI (B) and exposed to several antibiotics for 2 or 24 h. The results are expressed
as log10 values of CFU·(mL·cm2)−1. Plain white and dark grey bars illustrate 18- and 66-h-old biofilms
(r spectively) with 2-h-long antibiotic exposure, while striped white and dark grey bars illustrate 18-
and 66-h-old biofilms (respectively) with 24-h-long antibiotic exposure. The results of antibiotic-treated
biofilms were compared to TSB-treated biofilms. The statistical analysis was performed by using unpaired
t-tests with Welch’s correction. * p < 0.05 and *** p < 0.001 were considered statistically significant and
highly significant, respectively. Error bars denote the standard error of the mean (SEM) (n = 2).
A combination treatment of trypsin and levofloxacin on 18- and 66-h-old biofilms formed on HA
was tested. For this purpose, biofilms were first treated with trypsin (51.9 ng·µL−1) followed by a
90 µM levofloxacin treatment. Comparison of the results with the two controls (biofilms treated with
TSB or 100 mM TEAB followed by 90 µM levofloxacin) revealed that the trypsin treatment alone did not
benefit biofilm eradication (Figure 8). Statistically highly significant differences (p < 0.001) were only
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acquired when biofilms were treated with trypsin and levofloxacin in comparison with the TSB-treated
biofilms. Additionally, there was no difference between the trypsin- and levofloxacin-treated 18- and
66-h-old biofilms, indicating that the protein-dependent matrix network was already well-established
at the 18 h time point.
Table 3. The chemotolerance of S. aureus ATCC 25923 as quantified using the log reduction of viable
counts. The 18-h- and 66-h-old biofilms were formed on hydroxyapatite (HA) and titanium (TI), and
exposed to penicillin G, levofloxacin, doxycycline and vancomycin.
Biofilm Age BiofilmFormed on
Exposure
Time
Penicillin G
(2.0 µM) a
Levofloxacin
(90.0 µM) a
Doxycycline
(4.0 µM) a
Vancomycin
(5.0 µM) a
18 h HA 2 h 0.10 ± 0.28 0.56 ± 0.06 0.08 ± 0.15 0.03 ± 0.31
18 h TI 2 h 0.01 ± 0.19 1.39 ± 0.05***, ‡ ‡ ‡
0.59 ± 0.21
*, ‡ −0.17 ± 0.25
18 h HA 24 h 2.32 ± 0.18***, ‡ ‡ ‡, Ω
3.09 ± 0.04
***, ‡ ‡ ‡, Ω Ω Ω
2.00 ± 0.14
*, ‡, Ω Ω Ω
0.65 ± 0.09
Ω
18 h TI 24 h 1.28 ± 0.08‡
2.18 ± 0.15
‡ ‡ ‡, Ω Ω Ω
1.08 ± 0.20
Ω 0.33 ± 0.09
66 h HA 2 h 0.42 ± 0.04*
0.64 ± 0.24
*, ‡ 0.31 ± 0.08
0.61 ± 0.11
*, ‡
66 h TI 2 h 0.07 ± 0.15 0.46 ± 0.08 0.39 ± 0.06 0.24 ± 0.12
66 h HA 24 h 1.82 ± 0.24*, Ω Ω Ω
2.35 ± 0.07
***, Ω
1.32 ± 0.20
Ω 0.88 ± 0.38
66 h TI 24 h 0.94 ± 0.18Ω
1.76 ± 0.14
Ω Ω Ω
1.62 ± 0.04
*, ‡, Ω Ω Ω
1.67 ± 0.03
Ω
a The numbers refer to logR values (±SEM) indicating the difference between antibiotic- and medium-treated
coupons. *, p < 0.05 and ***, p < 0.001; differences between HA and TI, when the biofilm age and exposure time are
the same. ‡, p < 0.05 and ‡ ‡ ‡, p < 0.001; differences between the 18- and 66-h-old biofilms when the exposure times
and the materials are same. Ω, p < 0.05 and Ω Ω Ω, p < 0.001; differences between exposure times (2 h and 24 h)
when the biofilm age and the materials are the same. The statistical analyses were performed using unpaired t-tests
with Welch’s correction.
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4. Discussion
It is known that biofilm formation of S. aureus depends, among other factors, on the functional
characteristics of the indwelling medical device and the specific surface components of the bacterium.
However, many biofilm studies have traditionally utilized PS-based surface materials as the substrate
for promoting adherent/biofilm growth. The biggest drawback of such studies is that the obtained
results are not directly applicable to other clinically relevant substrate materials. In addition, instead of
systematic studies focusing on the biofilm substrates or the biofilm matrix components, the majority
of the studies have investigated the role of the individual materials or specific surface-anchored
components of the adhering S. aureus. The present study aimed at filling this gap in knowledge by
exploring structural features of five clinically pertinent materials and complementing the findings with
in-depth surfaceomics of S. aureus ATCC 25923 biofilms growing on those materials.
4.1. Structural Features and the Impact of PNAG on Biofilm Growth
The surface analyses of the tested substrate materials revealed considerable differences in
roughness, which, however, did not correlate with the biofilm formation efficiency. This suggests
that other physicochemical factors (such as surface charge and surface energy) might have played
a role in the biofilm–substrate interactions and could explain the material-dependent changes in
the number of exopolysaccharides (PNAG fraction) and protein. poly-N-acetyl-β-(1–6)-glucosamine
(PNAG; also referred to as polysaccharide intercellular adhesin (PIA)) is a major exopolysaccharide in
the Staphylococcus aureus biofilm matrix. It is partially deacetylated, and its synthesis is mediated by the
icaADBC locus [64,65]. Biofilms on PS and HA materials had the highest amount of PNAG at the 18 h
time point, but this content was reducing over time in all materials, with the deepest drop in TI biofilms.
In contrast, the protein amount was increasing towards the end of the growth. The most significant
increase in protein amount was detected with G and HA biofilms, while the highest elevation in the
number of proteins was detected with TI and HA biofilms. These findings suggest that PNAG has a
more important role than proteins in coordinating the adherence of the cells in young biofilms (18 h) on
PS and HA. In contrast, the protein role would switch to be more crucial at the later stages of biofilm
formation (contributing to material-specific adherence and/or maintaining biofilm integrity/stability).
PNAG has a net positive charge, which, besides promoting intercellular interactions by binding to the
negatively charged surfaces of neighboring cells, might additionally have stimulated the adherence to
negatively charged surfaces (such as those provided by the hydrophilic PS). Shifts in extracellular pH
due to metabolic fluctuations may have also affected the PNAG content, as pH has been shown to
control the EPS stability and thereby the mechanical properties of the S. aureus SH1000 biofilm [66].
PNAG is known to affect the attachment of staphylococcal biofilms, pathogenesis [67], resistance
to phagocytosis, polymorphonuclear leucocytes [68,69] and antibiotic tolerance [70]. We suggest
that among the materials studied here, PS and HA provide the best support for PNAG-stimulated
biofilm growth.
4.2. The Accessory and Core Surfaceomes of the S. aureus ATCC 25923 Biofilms
Greatest variations in surfaceomes were detected for TI-, HA- and G-associated biofilms already
at the 18 h time point. Virulence factors such as hemolysin HlgB and EsxA (a chaperone and/or an
adaptor protein, which interacts with host receptor proteins and interferes with host cell apoptotic
pathways) [71,72], were found moderately abundant in all biofilms at the 42 and 66 h time points.
Staphopain A (SspP), detected here in all biofilms (except on HA, at 18 h), has been proposed to
increase bacterial persistence through, e.g., degrading the antimicrobial human peptide LL-37 [73].
Immunodominant antigens IsaA and IsaB were dominating proteins in all biofilm samples. IsaA has
been proposed to have autolytic activity [74], while elevated IsaB-levels promote the virulence and
persistence of MRSA [75]. Increased abundance of IsaA has also been reported for Staphylococcus
epidermidis biofilms formed on TI [76], implying that this antigen could have mediated S. aureus biofilm
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formation on the selected materials in our study. Bifunctional autolysin (AtlA), identified on all materials
at every time point, has been reported to be responsible for initial attachment in biofilm formation,
bacterial cell wall degradation and cell separation during cell division [46,77]. In addition, this autolysin
is also reported with a potential role in FnBP-mediated biofilm maturation [78]. Our findings suggest
that FnBPA could be important in earlier stages of biofilm formation (in young biofilms, at the 18 h
time point), whereas the abundance of FbnBP in older biofilms implies this adhesin might have a more
prominent role in biofilm maturation.
Staphylococcal secretory antigen (SsaA) was one of the most abundant secreted antigens detected
in all biofilm samples (except on TI); this immunodominant antigen is suggested to be involved in
biofilm growth and biofilm-related infections [79,80]. The immunoglobulin-binding protein A (Spa),
identified on all materials at every time point, has been shown to be in a pivotal role in biofilm
formation [81]. Other potential surface adhesins, such as Ser-Asp repeat-containing protein C (SdrC),
ClfA, ClfB, Bbp and EbpS detected here in initial stages of biofilm growth on one or several of the tested
materials, could also play a role in promoting initial adherence to the tested materials. Glutamine
synthetase, with an ability to bind fibronectin, laminin, collagen I and plasminogen [82], was specifically
identified only in TI-associated biofilms, implying that biofilms formed on this substrate could interfere
with the host immune defense system.
4.3. The Surface-Associated Moonlighters Dominate in All Studied Biofilms
The cytoplasmic proteins with predicted multitasking functions [82,83] formed the biggest group
among all identified proteins, independent of the biofilm substrate used. The presence of cytoplasmic
proteins in the extracellular milieu has been widely explained with cell lysis/leakage. However, this
interpretation seems to be too simple, since several lines of evidence imply the existence of a yet
unknown mechanism controlling cytoplasmic protein excretion. For example, it has been noted that
cytoplasmic protein excretion is increased when the autolysins are up-regulated and peptidoglycan
cross-linking is decreased [84]. Cell lysis in S. aureus biofilms has been shown to depend on the presence
of the major autolysin Atl, the holin/antiholin system CidABC and LrgAB [78,85–87]. Atl has been
shown to be strongly upregulated in moderately aged S. aureus biofilms, which resulted in strong lysis
and accumulation of intracellular proteins in the biofilm matrix [47].
Thus, besides the conventional autolysin activity, AtlA can also control the excretion of cytoplasmic
proteins (e.g., EfTU) to the cell surface; a process that is not random, but suggested to involve selection
based on certain sequence motifs (e.g., α-helices) [84,87–89]. The Atl-mediated protein export could
also occur in vivo in S. aureus, indicated by recent results in the post-arthroplasty joint infection model
(hypodermic stainless-steel rod) where higher levels of cytoplasmic proteins were found, compared to
the classical surface adhesins or other classically secreted proteins [48]. From the cytoplasmic proteins,
GaPDH has been detected with increased abundances in S. epidermidis biofilms formed on TI [76],
indicating that this moonlighter could be important for biofilm formation or stability of the formed
biofilms. Besides their conventional roles in cytoplasm, the cytoplasmic proteins are reported to
have also adhesive (to plasminogen, laminin, Caco-2-cell, mucin, EPS-derived mannan or rhamnose),
immunomodulatory and/or biofilm formation stimulating functions [90–94].
Here, the r-protein moonlighters, bearing a high net positive charge with high affinity towards
anionic cell wall components (eDNA and anionic metabolites), formed the biggest group of the identified
moonlighting proteins. This is supported by [47], showing that r-proteins and several secreted virulence
proteins (both having a strong positive charge) are embedded in the acidic S. aureus biofilm matrix.
Acidic conditions are generated by the release of fermentation end-products as a response to oxygen
limitation in the biofilms. In that study, the r-proteins were suggested to contribute to the pH-dependent
stability of the biofilms. The r-proteins are classically involved in translation, but after associating with
cell surfaces, they could also function as a defensive mechanism in response to external challenges
originating from the host immune system, antibiotics or other challenges, as previously reported by [95].
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This has been supported by a recent proteomic study reporting that the production of r-proteins is
increased in response to an antibacterial agent, quinolonyl-oxazolidinone [96].
Our study also indicated the presence of several regulatory proteins normally acting in intracellular
milieu by coordinating biofilm growth, virulence and/or drug resistance [97] at biofilm cell surfaces.
S. aureus is also reported to use membrane vesicles (MVs) to transfer regulators, virulence factors and
drug resistance enzymes in a protected and concentrated manner [98–102]. Regulator proteins SarR,
SarS and Rot, as well as r-proteins, malate:quinone oxidoreductase 2 (MQO2), hemolysins, leukocidins,
certain moonlighters (EfG, EfTU, chaperone protein DnaJ, Usp, PYK, ENO, PDHB, ATP synthase
subunit beta), foldase protein A (PrsA) and penicillin-binding protein were previously identified from
MVs isolated from S. aureus 06ST1048 [101]. Notably, leukocidins have been shown to be efficiently
produced also during chronic infection in vivo [48], which further suggests that S. aureus can actively
modulate the host immune system even protected within the biofilm. Thus, it can be hypothesized that
these virulence factors are sorted into MVs for protected export, together with necessary moonlighters,
aiming at maintaining the cohesion and viability of the biofilm community in vivo.
4.4. Older Biofilms Are Not Always More Tolerant Than Younger Biofilms
Our findings suggested that PS, G and PG could provoke protein-dependent antibiotic resistance,
as the enzymes lysostaphin resistance protein A (LyrA) and methicillin resistance-associated FemA/B
and FmtA [103–105] were detected in PS, PG and/or G biofilms already at the 18 h time point,
implying that biofilms on other materials may be more susceptible to certain antibiotics. In our
study, chemotolerance tests were executed with different antibiotics covering a broad spectrum of
mechanisms of action: vancomycin (glycopeptide: inhibits cell wall synthesis by forming complexes
with peptidoglycan precursors [106]), penicillin G (B-lactam: inhibits cell wall synthesis via preventing
peptidoglycan polymerization [107]), doxycycline (tetracycline: inhibits protein synthesis by binding
to the 30S subunit of the bacterial ribosome [108]) and levofloxacin (fluoroquinolone: inhibits bacterial
DNA gyrase and topoisomerase IV in Gram-negative and Gram-positive bacteria, respectively, and
blocking DNA replication [109]). Furthermore, levofloxacin, vancomycin and doxycycline are used
as a part of treatment regimen in managing prosthetic joint infections caused by Staphylococcus spp.
Usually, vancomycin is administered intravenously for the first two weeks after the surgical therapy (if
oxacillin-, methicillin- or rifampicin-resistance has been observed), while doxycycline and levofloxacin
are given per oral as a continuation therapy (a total duration of antibiotic treatment is 12 weeks) [110].
Our results were in accordance with the results obtained by [111], where several antibiotics were tested
against Staphylococcus aureus ATCC 25923. Therein, levofloxacin was the most effective, followed
by doxycycline, penicillin G and vancomycin (least active). In our study, levofloxacin was the most
effective, while the second most active was penicillin G or doxycycline depending on the biofilm
age, used substrate material or exposure time of the antibiotic. Least active was vancomycin, as well.
Furthermore, in another study, doxycycline displayed higher activity than vancomycin against different
Staphylococcus aureus clinical isolates [112].
The results also revealed that in many cases, biofilms formed on HA were more susceptible to
antibiotics than biofilms on TI. Unexpectedly, the 66 h biofilms were not always more tolerant than
those grown for 18 h, which may suggest that other surface factors, such as the r-protein moonlighters
or other moonlighting proteins could have contributed to the observed phenotypes.
4.5. Several Biofilm Surfaceome Proteins Are Important for Successful Infection
Hemolysins, leukocidins, stress proteins (AhpC/F, Usp, SodA), resistance (FmtA), chaperones
(ClpL, ClpC, ClpB, DnaK and GroEL) and response regulators (VraR, CodY and CcpA) identified here
already at 18-h-old biofilms were recently suggested to be involved in host–pathogen interactions
in vivo [113]. Several of these proteins were also identified as secreted and/or matrix-associated
proteins in an implant-associated biofilm in vivo infection model [48]. In addition, the Clp family
proteins are reported to be important for biofilm formation and virulence [114]. The appearance of
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ClpP at the cell surface is interesting, as the enzyme can be activated by an acyldepsipeptide antibiotic
into a non-specific protease capable of killing S. aureus persisters [115].
5. Conclusions
The present study indicated the importance of PNAG and dedicated cell wall/membrane-anchored
proteins during the initial stages of biofilm formation. The recycling of cytoplasmic proteins as
moonlighting components could benefit biofilm population by increasing the integrity, stability and
drug resistance of the cells. As the development of the protein matrix was slowest on HA and TI, our
study proposes that these substrates could provide a good starting point for generating new clinical
materials with enhanced anti-biofilm features. Prior to this, as biofilms formed on HA were found to
reach sufficient maturity already at the 18 h time point, in-depth surfaceome analysis on this material
should be investigated also at earlier time points. Classical surface proteins have been considered as
the most attractive targets in drug design against bacterial pathogens. However, this research should
be expanded to also include non-classical moonlighters, as many of these can contribute to virulence
and drug tolerance. Thus, understanding mechanisms coordinating the moonlighting activity would
not only provide fundamental insights into bacterial gene regulation, but it may also shed better insight
into new strategies aimed at designing novel anti-biofilm agents/materials.
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